
Quest Diagnostics CEO Jim Davis Talks Outlook
Bloomberg Talks
00:00
Quest's oncology and pathology capabilities
Jim outlines Quest's large anatomical pathology business and follow-on cancer testing, including MRD via Haystack Oncology.
Play episode from 05:26
Transcript


